Nancy Guthrie, Sheriff Chris Nanos hit with $25 million lawsuit Gayle King says Oprah refused to shut down 'secretly gay' rumors Barron Trump skips Don Jr.'s wedding amid tension claims 'I didn't ...

Harrowing shark attack captured on camera Doctor gives major warning about chia seed trend: 'Definitely not' US begins 'self-defense strikes' against Iran, CENTCOM says What a study sidelined by the ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Following a brief trading halt, Regenxbio (RGNX) lost ~18% in the premarket on Thursday after the company, alongside its Q1 2026 results, posted late-stage trial data for RGX-202, a gene therapy ...

An experimental Intellia Therapeutics medicine that uses CRISPR technology to edit genes inside patients led to a significant reduction in attacks from a rare inherited swelling disorder after just a ...

For the research, Ray was provided with warehouse worker data covering 31 months from 2015 to 2017. During that span, the warehouse fulfilled approximately 8,000 orders per day and employed over 1,000 ...

The idea is to have one central reference for all our Python dependencies, DBT being one of them. UV makes this possible because it allows us to manage Python packages via a central lock file (uv.lock ...

LONDON, April 12 (Reuters) - British drugmaker GSK's (GSK.L), opens new tab experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after ...

Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. Georg Schett had ...

CLI tool for dbt data validation workflows. Born from the scripts folder of dbt-audit-helper-ext, this tool consolidates validation utilities into a proper Python package. Generate validation macros ...

A landmark Phase III trial published in The Lancet demonstrated a five-year overall survival rate of 90.9% for oropharyngeal cancer patients treated with proton therapy, compared with 81% for those ...

Providers treating chronic disease have always grappled with a fundamental disconnect that, in many cases, is considered unavoidable. The most critical determinants of a patient’s health — such as ...